Biopharma
Bio pharmaceutical is an umbrella term for medical drugs created with biotechnology. Beer, wine and washing detergent as well as systems used in agriculture and farming are all considered to be biotechnology. Research and innovation into biopharma is instrumental in the world of medicine and past discoveries have led to new ways to treat cancer and immune diseases.
The global management consultancy firm, McKinsey & Company noted that Biopharmaceuticals are “among the most sophisticated and elegant achievements of modern science.”
Composed of proteins and nucleic acids, biopharmaceuticals are often used for therapeutic or diagnostic purposes. The first such substance approved for therapeutic use was recombinant human insulin which has saved the lives of millions of diabetics around the world. Biopharma specifically refers to those pharmaceuticals derived from life forms including mammalian cells, bacteria, and yeast however often the definition is extended to include all types of pharmaceuticals.
Market Trends
PWC has recognised 7 major trends which are reshaping the biopharma marketplace in 2020:
- Chronic disease is becoming more common which places greater pressure on stretched healthcare budgets.
- Empowered consumers of healthcare services and policy makers are increasingly determining what doctors are able to prescribe.
- Greater access to data means that patients can track and measure the pharmacoeconomic performance of different medicines.
- Boundaries between different healthcare disciplines are blurring
- Demand for medicines is growing more rapidly in developing nations and emerging economies as opposed to industrialised economies.
- Preventative emphasis is overtaking treatments in government policy making intentions.
- Regulators are becoming more cautious about approving truly innovative medicines.
Industry Challenges and Opportunities
Bio-pharmaceutical innovators are met with a number of challenges such as rising consumer expectations. Patients want new therapies which are clinically and economically better than alternatives with real world data about why the medicine is superior. The well established discovering and developing process is traditionally slow to progress and management culture, mental models and strategies which are relied upon the industry are also slow to adapt.
Despite this, it is clear that trade is becoming easier, new medicines are materialising and demand for products is escalating.
It is predicted that the global pharmaceutical market could be worth nearly $1.6 trillion by 2020.
Contact our team, who can help you:
- Set up your business
- Find an existing business looking for investment
- Find the right talent and partnerships
- Grow and develop your business
我们的专职顾问将协助：
- 将企业家与企业联系起来，以帮助制定商业计划
- 谈判投资条款并完成交易
- 协助遵守英国内政部关于创新，可行性和可扩展性的指南
- 准备尽职调查报告以支持认可申请
- 提供营业额和利润的实时估算
- 引入对数据源的改进，从而产生更加一致的业务活动度量。
- 对您的估值进行建模并确定要提供多少权益
- 专门的律师就投资合同提供建议
- 准备您的商业计划书
- 开设UL银行账户和投资账户
- 住宅物业购买
- Applications for SEIS & EIS advance assurance
- 帮助您避免常见错误
了解更多
A Turkish Manufacturing Property Boom Driven by Asian Investors
The E-2 Visa – Bridging the gap to the EB-5
The COVID-19 effect on the Property Market
